Search - tctmd.com

Displaying 341 - 360 of 973

Sort: Relevancy | Date

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

News Daily News

Weekend Warriors vs Regular Exercisers: Some Insights, More Questions

Yael L. Maxwell

July 06, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Features

Climate Cardiology: If Not Now, When?

Caitlin E. Cox

June 20, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

L.A. McKeown

June 06, 2022

News Daily News

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Yael L. Maxwell

May 30, 2022

News Conference News EAS 2022

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Michael O'Riordan

May 27, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Yael L. Maxwell

May 12, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

Advertisement

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Weekend Warriors vs Regular Exercisers: Some Insights, More Questions

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Climate Cardiology: If Not Now, When?

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

Social Factors Contribute to Race Differences in Premature CVD: CARDIA

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Dapagliflozin Boosts Health Status Across LVEF Range

New CAC Risk Tool Helps Contextualize Scores for Younger Adults

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content